Retina Vitreous Associates of Florida — St. Petersburg, Florida

Public research footprint of Retina Vitreous Associates of Florida, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Geographic Atrophy · Diabetic Macular Edema · Neovascular Age-related Macular Degeneration · Wet Age-related Macular Degeneration

Recently updated registry entries

NCT05407636 — Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD (Active Not Recruiting)
NCT06541704 — A Study Investigating Subcutaneously Administered Pozelimab in Combination With… (Recruiting)
NCT07440225 — A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002) (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Retina Vitreous Associates of Florida?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.